Hong Kong Blood-based Biomaker For Sports Medicine Market Size & Outlook
Hong Kong blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Hong Kong blood-based biomaker for sports medicine market highlights
- The Hong Kong blood-based biomaker for sports medicine market generated a revenue of USD 3.1 million in 2023 and is expected to reach USD 4.3 million by 2030.
- The Hong Kong market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 3.1 million |
| Market revenue in 2030 | USD 4.3 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Hong Kong accounted for 0.5% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 19.35% in 2023. Horizon Databook has segmented the Hong Kong blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Hong Kong, increasing investment in sports is expected to drive a significant rise in participation and development. The government’s commitment to enhancing sports infrastructure and promoting physical activity has created a robust environment for athlete advancement. For instance, in the 2023-24 fiscal year, the government allocated USD 110 million to the sports institute.
This growing focus on sports is expected to improve the demand for advanced medical technologies, including blood-based biomarkers in sports medicine. As Hong Kong’s sports sector continues to expand, integrating these biomarkers into sports medicine is likely to grow, supported by ongoing investments and advancements in healthcare technology.
This trend highlights the country’s dedication to improving athlete care and achieving excellence in sports performance. Furthermore, as sports become more competitive and athletes strive for peak performance, there is a growing demand for precise & innovative methods to monitor and enhance their health.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Hong Kong blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Hong Kong Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
